Cargando…

The role of Xeloda in metastasic breast cancer

Detalles Bibliográficos
Autor principal:	Cortés-Funes, H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2005
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4231910/ http://dx.doi.org/10.1186/bcr1230

Ejemplares similares

Neratinib, an irreversible pan erB receptor tyrosine kinase inhibitor active for advanced HER2(+ )breast cancer
por: Cortés-Funes, H, et al.
Publicado: (2009)

Comparison of apatinib and capecitabine (Xeloda) with capecitabine (Xeloda) in advanced triple-negative breast cancer as third-line therapy: A retrospective study
por: Li, Yi-Hui, et al.
Publicado: (2018)

Low-dose capecitabine (Xeloda) for treatment for gastrointestinal cancer
por: Miger, Jasmine, et al.
Publicado: (2014)

SOLTI (Solid Tumor Intensification) Group experience with high-dose chemotherapy treatment for early breast carcinoma
por: Funes, H Cortés, et al.
Publicado: (2005)

A phase II trial of capecitabine (Xeloda®) in recurrent ovarian cancer
por: Vasey, P A, et al.
Publicado: (2003)

Treatment of ampullary neuroendocrine tumor by Capecitabine (Xeloda®) and Temozolomide (Temodal®)
por: Noorali, Sima, et al.
Publicado: (2021)

The role of the tumor microenvironment in breast cancer progression
por: Min, H, et al.
Publicado: (2005)

Future role of bevacizumab in breast cancer
por: Conte, PF, et al.
Publicado: (2009)

The role of megakaryocytes in breast cancer metastasis to bone
por: Stiffin, Rose Mary, et al.
Publicado: (2011)

Percutaneous treatment of liver metastases
por: Erinjeri, Joseph P
Publicado: (2015)

A dose-escalation study of indisulam in combination with capecitabine (Xeloda) in patients with solid tumours
por: Siegel-Lakhai, W S, et al.
Publicado: (2008)

Randomised, phase II trial comparing oral capecitabine (Xeloda®) with paclitaxel in patients with metastatic/advanced breast cancer pretreated with anthracyclines
por: Talbot, D C, et al.
Publicado: (2002)

Chromosome translocations may play a significant role in breast cancer
por: Howarth, KL, et al.
Publicado: (2006)

Role of the ATM gene in radiation sensitivity, relevance to breast cancer treatment
por: Hall, J, et al.
Publicado: (2000)

Evaluating tumour response to primary radiochemotherapy in breast cancer patients: what role for breast magnetic resonance imaging?
por: Thibault, F, et al.
Publicado: (2008)

The role of gene expression profiling by microarray analysis for prognostic classification of breast cancer
por: van de Vijver, MJ
Publicado: (2005)

Translational breast cancer research in luminal breast cancer
por: Dowsett, M
Publicado: (2011)

In vitro anti-proliferative effect of capecitabine (Xeloda) combined with mocetinostat (MGCD0103) in 4T1 breast cancer cell line by immunoblotting
por: Kaya Çakir, Hacer, et al.
Publicado: (2021)

Epigenetics of breast cancer
por: Esteller, M
Publicado: (2011)

Stem cells in normal breast development and breast cancer
por: Wicha, MS, et al.
Publicado: (2003)

Long-term survival of interval breast cancers in breast cancer screening in Wales
por: Fong, YF, et al.
Publicado: (2012)

The use of bilateral whole breast ultrasound to identify multifocal disease in newly diagnosed breast cancer
por: Wilkinson, LS, et al.
Publicado: (2004)

Interval cancer review in the Leicestershire symptomatic breast service
por: Tennant, SL, et al.
Publicado: (2009)

The future of breast cancer prevention
por: Howell, A, et al.
Publicado: (2005)

Genomic profiling of breast cancer
por: Borg, Å
Publicado: (2005)

The role of magnetic resonance imaging as an imaging tool to assess disease status and residual disease in locally advanced breast cancer
por: Cristofanilli, M
Publicado: (2005)

Mouse models for BRCA1-associated breast cancer
por: Wang, R-H, et al.
Publicado: (2003)

MR-guided focused ultrasound for painful bone metastases: safety when combined with chemotherapy
por: Meyer, Joshua, et al.
Publicado: (2015)

Update on breast cancer genetics
por: Izatt, L
Publicado: (2006)

Clinical breast cancer and estrogen
por: Chew, HK
Publicado: (2003)

Predictive factors in breast cancer
por: Klijn, J, et al.
Publicado: (2000)

Immunity and autoimmunity in breast cancer
por: Curigliano, G
Publicado: (2011)

Xeloda Oral, Trastuzumab, and Pertuzumab Combined Drug Therapy Reduced Cervical Lymphadenopathy and Dermal Involvement in Patient With Recurrent Breast Cancer: Case Report
por: Saure Sarría, Victor Manuel, et al.
Publicado: (2020)

Is ultrasound axillary staging less accurate in invasive lobular breast cancer than in ductal breast cancer?
por: Sankaye, P, et al.
Publicado: (2012)

Oral vinorelbine in metastatic breast cancer
por: Conte, PF, et al.
Publicado: (2005)

ATM mutations associated with breast cancer
por: Gatti, RA, et al.
Publicado: (2005)

Functional genomic approaches to breast cancer
por: Bernards, R
Publicado: (2005)

Multidetector CT Improving Surgical Outcomes in Breast Cancer (MISO BC)
por: Cox, J, et al.
Publicado: (2014)

Promoting early presentation of breast cancer
por: Ramirez, AJ
Publicado: (2008)

Developing new treatments for breast cancer
por: Lane, D
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_20e39on8g3tg50sq487viv10kv